Neurofibromatosis Type 1-Related Plexiform Neurofibromas: Key Advances from the 2025 Annual Oncology Conference (Chicago)*
Released On
June 3, 2025
Expires On
May 31, 2026
Media Type
Internet
Completion Time
15 minutes
Specialty
Hematology-Oncology, Neurology, Pediatrics
Topic(s)
NF1-PN
Provider Statement
This activity is provided in collaboration with Rush University Medical Center and Practice Point Communications®
This activity is supported in part by an independent education grant from Alexion, AstraZeneca Rare Disease.
Credit Available
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit(s)™
- Nurses — 0.25 Nursing Contact Hours
- Pharmacists — 0.25 Pharmacy Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity is designed to meet the educational needs of pediatric oncology and neurology specialists (physicians, physician assistants, registered nurses, and nurse practitioners) who care for persons with NF1-PN.
Program Overview
Pediatric and adult patients with plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1) are in need of efficacious therapies and there continues to be considerable progress in the field. Dr. Amy Armstrong highlights key clinical evidence in NF1-PN presented at the 2025 Annual Oncology Meeting in this brief Clinical Clip video.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Evaluate key evidence on available and emerging therapies for the treatment of NF1-PN that is presented at ASCO 2025
- Identify patient subsets with NF1-PN that will benefit from recently reported evidence
Faculty
Amy Armstrong, MD
Assistant Professor of Pediatrics
Division of Hematology/Oncology
Neurofibromatosis (NF) Center
Washington University School of Medicine
St. Louis, Missouri
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Rush University Medical Center and Practice Point Communications. Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Rush University Medical Center designates this enduring activity for a maximum of .25 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Conflicts of Interest
Amy Armstrong, MD
- Consultant: SpringWorks
- Advisor: Alexion, SpringWorks
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Rush University Medical Center requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
* This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.